Organon (OGN) Revenue (2020 - 2026)

Organon's Revenue history runs 7 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Revenue fell 3.5% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $6.2 billion (down 2.08% YoY), while the FY2025 annual figure was $6.2 billion, down 2.92% from the prior year.
• Revenue was $1.5 billion for Q1 2026 at Organon, down from $1.5 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.6 billion in Q1 2024 to a low of $1.5 billion in Q1 2026.
• Historically, Revenue has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Revenue decreased 7.36% in 2022, then increased 7.61% in 2023.
• A 5-year view of Revenue shows it stood at $1.5 billion in 2022, then advanced by 7.61% to $1.6 billion in 2023, then fell by 0.38% to $1.6 billion in 2024, then decreased by 5.34% to $1.5 billion in 2025, then decreased by 3.12% to $1.5 billion in 2026.
• The last three Revenue figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.